Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The British Thyroid Association guidelines for the management of thyroid cancer in adults.

× No keyword cloud information.

20 in total

1. Recurrent laryngeal nerve and voice preservation: routine identification and appropriate assessment - two important steps in thyroid surgery.

Authors: Ravindra Singh Mohil; Pragnesh Desai; Nitisha Narayan; Maheswar Sahoo; Dinesh Bhatnagar; V P Venkatachalam
Journal: Ann R Coll Surg Engl Date: 2010-08-19 Impact factor: 1.891

Review 2. Advances in the follow-up of differentiated or medullary thyroid cancer.

Authors: Rossella Elisei; Aldo Pinchera
Journal: Nat Rev Endocrinol Date: 2012-04-03 Impact factor: 43.330

3. Reliability of Thyroid FNAC as a Single Diagnostic Modality: A Systematic Review.

Authors: Jayita Poduval; Vinay Bhat; Paresh Naik
Journal: Indian J Otolaryngol Head Neck Surg Date: 2017-08-18

4. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.

Authors: Iain J Nixon; Monica M Whitcher; Frank L Palmer; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal: Thyroid Date: 2012-07-24 Impact factor: 6.568

Review 5. [Reoperation for thyroid cancer].

Authors: H Vogelsang; T Brückner; K Scheidhauer; M Schwaiger; J R Siewert
Journal: Chirurg Date: 2005-03 Impact factor: 0.955

6. Postoperative laryngoscopy in thyroid surgery: proper timing to detect recurrent laryngeal nerve injury.

Authors: Gianlorenzo Dionigi; Luigi Boni; Francesca Rovera; Stefano Rausei; Paolo Castelnuovo; Renzo Dionigi
Journal: Langenbecks Arch Surg Date: 2009-12-15 Impact factor: 3.445

7. The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.

Authors: Daniele Barbaro; Roberto Mario Incensati; Gabriele Materazzi; Giuseppe Boni; Mariano Grosso; Erica Panicucci; Paola Lapi; Cristina Pasquini; Paolo Miccoli
Journal: Endocrine Date: 2013-08-08 Impact factor: 3.633

8. The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.

Authors: Agnieszka Czarniecka; Monika Kowal; Dagmara Rusinek; Jolanta Krajewska; Michal Jarzab; Ewa Stobiecka; Ewa Chmielik; Ewa Zembala-Nozynska; Stanislaw Poltorak; Aleksander Sacher; Adam Maciejewski; Jadwiga Zebracka-Gala; Dariusz Lange; Malgorzata Oczko-Wojciechowska; Daria Handkiewicz-Junak; Barbara Jarzab
Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240

9. I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.

Authors: Yan Shengguang; Choi Ji-Eun; He Li Lijuan
Journal: Med Sci Monit Date: 2016-07-13

10. Calculation of Blood Dose in Patients Treated With 131I Using MIRD, Imaging, and Blood Sampling Methods.

Authors: Elham Piruzan; Mahdi Haghighatafshar; Reza Faghihi; Seyed Mohammad Entezarmahdi
Journal: Medicine (Baltimore) Date: 2016-03 Impact factor: 1.889